Deliver Your News to the World

CybeRelease: (OTC: MNCL) Begins Radio Talk Show Tour


(CybeRelease, March 8, 2007) – Lake Harmony, Pa. - Martin Nutraceuticals, Inc. (OTC PK: MNCL) announced it has commenced a campaign to feature its product spokesperson, Dr. Anthony Martin, on numerous radio stations throughout America and Canada. Mr. Harvey Panesar, President of Martin Nutraceuticals, enthusiastically reported that “this is a natural follow up to Dr. Martin’s own radio show ’Be Your Best: Real Nutrition Talk’ which developed a significant market share. We are excited that Tony will now be taking his straight talk about nutrition directly to the people and we know that his message will captivate listeners. This additional venue will certainly result in increased sales of our flagship products and of Dr. Martin’s new breakthrough book, ’Medical Crisis: Secrets your Doctor won’t share with You’.”

Dr. Martin will kick off his tour this Thursday, March 8th, 2007 on the program “On Target Ottawa” on 580 CFRA, one of the largest radio networks in Ontario. The show will air from 5 am to 6 am EST and will cover a host of different topics. Dr. Martin has been asked to guest on the show to cover the topic of Getting Rid of Negative Lifestyle Habits. To visit the website of CFRA 580 please visit:

“Tony (Dr. Martin) is doing a fantastic job, creating a great buzz for the book, Medical Crisis and we are excited about the opportunities which are arising,” continues Mr. Panesar. “The book is a great, easy read and we are very pleased about the reception that it is receiving.”

About Martin Nutraceuticals, Inc.

Martin Nutraceuticals, Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control.

Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days.

To read the complete release, go to

CybeRelease Gainers are Foster Wheeler Ltd. (Nasdaq: FWLT), Kronos Incorporated (Nasdaq: KRON), ATP Oil & Gas Corporation (Nasdaq: ATPG), Millicom International Cellular S.A. (Nasdaq: MICC), Gen-Probe Incorporated (Nasdaq: GPRO), Portfolio Recovery Associates, Inc. (Nasdaq: PRAA), FARO Technologies, Inc. (Nasdaq: FARO) and Central European Media Enterprises Ltd. (Nasdaq: CETV).

CybeRelease Decliners are Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH), EFJ Inc. (Nasdaq: EFJI), International Speedway Corporation (Nasdaq: ISCA), Itron, Inc. (Nasdaq: ITRI), Central European Distribution Corporation (Nasdaq: CEDC), Hittite Microwave Corporation (Nasdaq: HITT), Equinix, Inc. (Nasdaq: EQIX) and Covansys Corporation (Nasdaq: CVNS).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.